scispace - formally typeset
F

Frank Robledo-Avila

Researcher at Nationwide Children's Hospital

Publications -  25
Citations -  423

Frank Robledo-Avila is an academic researcher from Nationwide Children's Hospital. The author has contributed to research in topics: Immune system & Cystic fibrosis. The author has an hindex of 10, co-authored 21 publications receiving 248 citations. Previous affiliations of Frank Robledo-Avila include Instituto Politécnico Nacional & Ohio State University.

Papers
More filters
Journal ArticleDOI

Z-form extracellular DNA is a structural component of the bacterial biofilm matrix

TL;DR: In this article, the role of Z-DNA in biofilm pathogenesis, innate immune response, and immune evasion was investigated and it was shown that the universal bacterial DNABII family of proteins stabilizes both bacterial and host eDNA in the Z-form in situ.
Journal ArticleDOI

Dysregulated Calcium Homeostasis in Cystic Fibrosis Neutrophils Leads to Deficient Antimicrobial Responses.

TL;DR: It is suggested that regulation of neutrophil Ca2+ homeostasis (via CFTR potentiation or by the regulation ofCa2+ channels) can be used as a new therapeutic approach for reestablishing immune function in patients with CF.
Journal ArticleDOI

Human Cystic Fibrosis Macrophages Have Defective Calcium-Dependent Protein Kinase C Activation of the NADPH Oxidase, an Effect Augmented by Burkholderia cenocepacia.

TL;DR: Analysis of CF and non-CF human monocyte-derived macrophages for ROS production, NADPH assembly capacity, protein kinase C expression, and calcium release in response to PMA and CF pathogens implicate a critical role for defective macrophage oxidative responses in persistent bacterial infections in CF.
Journal ArticleDOI

Whole-blood transcriptomic responses to lumacaftor/ivacaftor therapy in cystic fibrosis

TL;DR: In this paper, a whole-blood transcriptomics was performed using RNA-Seq in 20 patients with CF pre-and 6 months post-lumacaftor/ivacaftors (drug) initiation and 20 non-CF healthy controls.